These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7350458)

  • 1. The FDA's classification system for new drugs. An evaluation of therapeutic gain.
    Finkel MJ
    N Engl J Med; 1980 Jan; 302(3):181-3. PubMed ID: 7350458
    [No Abstract]   [Full Text] [Related]  

  • 2. Understanding the FDA's guarded system for classifying new drugs.
    Schneiweiss F
    Hosp Pharm; 1979 May; 14(5):262-4, 266, 268 passim. PubMed ID: 10316828
    [No Abstract]   [Full Text] [Related]  

  • 3. FDA's classification of new drugs.
    Schneiweiss F
    N Engl J Med; 1980 Jun; 302(24):1368-9. PubMed ID: 7374693
    [No Abstract]   [Full Text] [Related]  

  • 4. The FDA's new drug rating system.
    Ohio Med; 1991 Mar; 87(3):133-4. PubMed ID: 2030884
    [No Abstract]   [Full Text] [Related]  

  • 5. Linking a policy on nonformulary drugs to the FDA's therapeutic-potential classification system.
    Poirier TI; Vorbach M; Bache T
    Am J Hosp Pharm; 1994 Sep; 51(18):2277-8. PubMed ID: 7801989
    [No Abstract]   [Full Text] [Related]  

  • 6. Export of pharmaceuticals and medical devices under the federal Food, Drug & Cosmetic Act: FDA's striking change in interpretation post-Shelhigh.
    Basile EM; Tolomeo D; Gluck E
    Food Drug Law J; 2009; 64(1):149-69. PubMed ID: 19998744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FDA drug classification system.
    Sanborn MD; Godwin HN; Pessetto JD
    Am J Hosp Pharm; 1991 Dec; 48(12):2659-62. PubMed ID: 1814217
    [TBL] [Abstract][Full Text] [Related]  

  • 8. FDA's biomedical research program.
    Kelsey FO
    J Parenter Drug Assoc; 1980; 34(2):134-8. PubMed ID: 6989974
    [No Abstract]   [Full Text] [Related]  

  • 9. FDA's Bioresearch Monitoring Program.
    Kelsey FO
    Methods Find Exp Clin Pharmacol; 1982; 4(7):503-8. PubMed ID: 7169836
    [No Abstract]   [Full Text] [Related]  

  • 10. The FDA's response to AIDS: paradigm shift in new drug policy?
    Podraza R
    Food Drug Law J; 1993; 48(3):351-75. PubMed ID: 11653267
    [No Abstract]   [Full Text] [Related]  

  • 11. Classification and coding considerations for drug data base design.
    Forbes MB
    J Clin Comput; 1983; 12(3):88-100. PubMed ID: 10317426
    [No Abstract]   [Full Text] [Related]  

  • 12. FDA new drug approvals in 2009.
    Wynn RL
    Gen Dent; 2010; 58(4):280-4. PubMed ID: 20591770
    [No Abstract]   [Full Text] [Related]  

  • 13. Highlights and a hidden hazard--the FDA's new labeling regulations.
    Avorn J; Shrank W
    N Engl J Med; 2006 Jun; 354(23):2409-11. PubMed ID: 16760439
    [No Abstract]   [Full Text] [Related]  

  • 14. [FDA's new drug approval system].
    Ishii A
    Gan To Kagaku Ryoho; 1995 Aug; 22(9):1146-51. PubMed ID: 7661565
    [No Abstract]   [Full Text] [Related]  

  • 15. FDA's perspective on women and drugs.
    Danello MA
    NIDA Res Monogr; 1986; 65():9-13. PubMed ID: 3090447
    [No Abstract]   [Full Text] [Related]  

  • 16. FDA's new rule on treatment use and sale of investigational new drugs.
    Levine RJ
    IRB; 1987; 9(4):1-4. PubMed ID: 11649946
    [No Abstract]   [Full Text] [Related]  

  • 17. PDA's response to FDA's "Guideline on sterile drug products produced by aseptic processing".
    Akers JE; Agalloco JP; Carleton FJ; Korczynski MS
    J Parenter Sci Technol; 1988; 42(4):114-7. PubMed ID: 3183865
    [No Abstract]   [Full Text] [Related]  

  • 18. Upon closer inspection. As the U.S. imports more drugs and devices, the FDA's overseas initiatives aim to head off trouble at the source.
    Rhea S
    Mod Healthc; 2009 Mar; 39(13):28-30. PubMed ID: 19405431
    [No Abstract]   [Full Text] [Related]  

  • 19. Implications of FDA's proposal to include foreign marketing experience in the over-the-counter drug review process.
    Pinco RG
    Food Drug Law J; 1998; 53(1):105-22. PubMed ID: 11795327
    [No Abstract]   [Full Text] [Related]  

  • 20. Impact of FDA's new drug rule? Not much.
    Holthaus D
    Hospitals; 1987 Aug; 61(15):106. PubMed ID: 3596532
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.